Sensible Financial Planning & Management LLC. Sells 1,520 Shares of Cabot Co. (NYSE:CBT)

Sensible Financial Planning & Management LLC. decreased its position in shares of Cabot Co. (NYSE:CBTFree Report) by 4.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 31,540 shares of the specialty chemicals company’s stock after selling 1,520 shares during the quarter. Cabot makes up 0.6% of Sensible Financial Planning & Management LLC.’s investment portfolio, making the stock its 22nd largest position. Sensible Financial Planning & Management LLC. owned approximately 0.06% of Cabot worth $2,634,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in CBT. Envestnet Asset Management Inc. boosted its stake in Cabot by 92.7% in the 3rd quarter. Envestnet Asset Management Inc. now owns 288,216 shares of the specialty chemicals company’s stock worth $19,965,000 after purchasing an additional 138,663 shares during the period. AQR Capital Management LLC boosted its stake in Cabot by 350.6% in the 3rd quarter. AQR Capital Management LLC now owns 176,452 shares of the specialty chemicals company’s stock worth $12,223,000 after purchasing an additional 137,294 shares during the period. Assenagon Asset Management S.A. boosted its stake in Cabot by 176.4% in the 4th quarter. Assenagon Asset Management S.A. now owns 124,422 shares of the specialty chemicals company’s stock worth $10,389,000 after purchasing an additional 79,410 shares during the period. Vontobel Holding Ltd. bought a new position in Cabot in the 4th quarter worth about $6,248,000. Finally, Victory Capital Management Inc. boosted its stake in Cabot by 541.7% in the 3rd quarter. Victory Capital Management Inc. now owns 82,090 shares of the specialty chemicals company’s stock worth $5,686,000 after purchasing an additional 69,298 shares during the period. Institutional investors own 93.18% of the company’s stock.

Insider Activity at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of the business’s stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $79.91, for a total value of $4,413,669.03. Following the sale, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at $7,767,331.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.07% of the stock is currently owned by corporate insiders.

Cabot Trading Up 0.0 %

Shares of CBT stock traded up $0.04 during trading hours on Wednesday, reaching $93.42. The company’s stock had a trading volume of 178,621 shares, compared to its average volume of 304,681. The stock has a market capitalization of $5.18 billion, a P/E ratio of 12.13, a P/E/G ratio of 0.98 and a beta of 1.28. Cabot Co. has a one year low of $63.73 and a one year high of $98.34. The firm’s fifty day simple moving average is $88.80 and its 200 day simple moving average is $80.17. The company has a current ratio of 2.04, a quick ratio of 1.30 and a debt-to-equity ratio of 0.74.

Cabot (NYSE:CBTGet Free Report) last released its quarterly earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.07. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The company had revenue of $958.00 million for the quarter, compared to analyst estimates of $927.28 million. Equities research analysts expect that Cabot Co. will post 6.58 EPS for the current year.

Analyst Ratings Changes

Several analysts have weighed in on the company. StockNews.com cut Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Deutsche Bank Aktiengesellschaft cut Cabot from a “buy” rating to a “hold” rating and raised their price target for the company from $88.00 to $95.00 in a report on Thursday, April 18th. Mizuho assumed coverage on Cabot in a report on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price target on the stock. Finally, UBS Group cut Cabot from a “buy” rating to a “neutral” rating and lowered their price target for the company from $90.00 to $87.00 in a report on Monday, January 8th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.17.

View Our Latest Analysis on CBT

Cabot Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.